Literature DB >> 17960611

Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.

Jillian de Wilde1, Saskia M Wilting, Chris J L M Meijer, Mark A van de Wiel, Bauke Ylstra, Peter J F Snijders, Renske D M Steenbergen.   

Abstract

Although high-risk human papillomavirus (HPV) infection plays a major role in the development of cervical cancer, additive oncogenic events are involved as well. One key event involves increased activity of telomerase resulting from a deregulated expression of its catalytic subunit hTERT. Our previous microcell-mediated chromosome transfer studies revealed that introduction of human chromosome 6 in the HPV16-immortalized keratinocyte cell line FK16A and in the HPV16-containing cervical cancer cell line SiHa induced growth arrest, resulting from a repression of hTERT mRNA expression and telomerase activity. Here, this model was used to analyze expression profiles associated with hTERT deregulation in HPV-transformed cells. Microarray expression analysis of 12 FK16A/chromosome 6 hybrids, 4 of which were negative for endogenous hTERT and 8 of which were positive for endogenous hTERT, resulted in the identification of 164 differentially expressed genes. Differential expression of a selection of 5 genes was verified by real-time RT-PCR. Of these 164 genes, 32 were also differentially expressed in other HPV transformed cells with deregulated hTERT. For 2 of these genes, encoding AQP3 and MGP, altered expression in hTERT positive cervical carcinomas was confirmed by real-time RT-PCR and immunohistochemistry, respectively. Moreover, increased MGP protein expression was significantly more frequent in high-grade cervical premalignant lesions with elevated hTERT mRNA expression compared to those without. In summary, we identified 32 candidate biomarkers for deregulated hTERT mRNA expression, which may enable the identification of cervical premalignant lesions that are at highest risk to progress to invasive cancer. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17960611     DOI: 10.1002/ijc.23210

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

2.  Identification of differential expressed transcripts in cervical cancer of Mexican patients.

Authors:  Leticia Santos; Ma Fabiola León-Galván; Erika Nahomy Marino-Marmolejo; Ana Paulina Barba de la Rosa; Antonio De León Rodríguez; Roberto González-Amaro; Ramón Gerardo Guevara-González
Journal:  Tumour Biol       Date:  2011-01-13

3.  The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.

Authors:  Pauline J van der Watt; Christopher P Maske; Denver T Hendricks; M Iqbal Parker; Lynette Denny; Dhirendra Govender; Michael J Birrer; Virna D Leaner
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

4.  PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro.

Authors:  Florianne E Henken; N Sanjib Banerjee; Peter J F Snijders; Chris J L M Meijer; Johanna De-Castro Arce; Frank Rösl; Thomas R Broker; Louise T Chow; Renske D M Steenbergen
Journal:  Mol Cancer       Date:  2011-06-10       Impact factor: 27.401

5.  A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens.

Authors:  Bogumil Kaczkowski; Marya Morevati; Maria Rossing; Finn Cilius; Bodil Norrild
Journal:  Open Virol J       Date:  2012-12-28

Review 6.  A review of methods for detect human Papillomavirus infection.

Authors:  André L P Abreu; Raquel P Souza; Fabrícia Gimenes; Marcia E L Consolaro
Journal:  Virol J       Date:  2012-11-06       Impact factor: 4.099

Review 7.  Matrix Gla protein in tumoral pathology.

Authors:  Simona Roxana Gheorghe; Alexandra Mărioara Crăciun
Journal:  Clujul Med       Date:  2016-07-28

8.  The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines.

Authors:  Karolina Sterzyńska; Andrzej Klejewski; Karolina Wojtowicz; Monika Świerczewska; Małgorzata Andrzejewska; Damian Rusek; Maciej Sobkowski; Witold Kędzia; Jacek Brązert; Michał Nowicki; Radosław Januchowski
Journal:  Int J Mol Sci       Date:  2018-09-25       Impact factor: 5.923

9.  Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.

Authors:  Mizhu Wang; Lei Chen; Yu Chen; Rui Wei; Qingdong Guo; Shengquan Zhu; Shuilong Guo; Shengtao Zhu; Shutian Zhang; Li Min
Journal:  Mol Oncol       Date:  2020-03-16       Impact factor: 6.603

10.  Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.

Authors:  F E Henken; S M Wilting; R M Overmeer; J G I van Rietschoten; A O H Nygren; A Errami; J P Schouten; C J L M Meijer; P J F Snijders; R D M Steenbergen
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.